Operating Lease, Right-of-Use Asset of Indaptus Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Indaptus Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Indaptus Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $8,487, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Indaptus Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,487 -$97,168 -92% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $33,577 -$95,053 -74% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $58,119 -$92,999 -62% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $82,175 -$91,031 -53% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $105,655 -$89,096 -46% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $128,630 -$87,216 -40% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $151,118 -$85,388 -36% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $173,206 +$93,912 +118% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $194,751 +$92,497 +90% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $215,846 +$90,993 +73% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $236,506 +$89,404 +61% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $79,294 -$89,794 -53% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $102,254 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $124,853 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $147,102 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $169,088 -$647,912 -79% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q4 2020 $817,000 31 Dec 2020 10-Q 16 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.